Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Dec 29;32(3):439–447. doi: 10.3346/jkms.2017.32.3.439

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 The Korean Academy of Medical Sciences.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Fig. 1 — Comparisons of FeNO levels in ACOS patients with different disease severity and the control group before and after treatment.

A = mild ACOS group, B = moderate ACOS group, C = severe ACOS group, D = extremely severe ACOS group, FeNO = fractional exhaled nitric oxide, Before = before the 6-month treatment, After = after the 6-month treatment, ACOS = asthma-chronic obstructive pulmonary disease overlap syndrome.

^*P < 0.05, compared with the control group before treatment; ^†P < 0.05, compared with the control group after treatment; ^‡P < 0.05 when compared with the mild ACOS, moderate ACOS, severe ACOS, extremely severe ACOS, and control groups.